复制独立的ICL修复:从化疗到细胞平衡
Arooba Ahmed1, Niyo Kato1, Jean Gautier2
1Institute for Cancer Genetics, Columbia University Vagelos, College of Physicians and Surgeons, New York, NY, USA.
Journal of molecular biology
|May 19, 2024
概括
跨链交叉链 (ICLs) 是DNA损伤,可能导致细胞死亡,并且是化疗的目标. 这项研究探讨了独立于DNA复制的ICL修复途径,将修复效率与衰老和疾病联系起来.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 细胞生物学 细胞生物学
背景情况:
- 跨链交叉链 (ICL) 是阻碍DNA复制和转录的DNA病变,通常导致细胞死亡.
- 诱导ICL的药物用于化疗,因为它们具有强大的抗增殖作用.
- 内生代谢过程可以产生ICL,对基因组稳定性构成威胁,特别是在静止细胞中.
研究的目的:
- 阐明复制独立的跨链交叉连接修复路径的机制.
- 研究ICL修复效率与衰老和疾病发展过程之间的相关性.
主要方法:
- 审查有关DNA修复机制的现有文献.
- 在不同细胞周期阶段对ICL细胞反应的分析.
- 在衰老和疾病模型中对ICL修复效率的比较研究.
主要成果:
- 识别和描述多个独立于DNA复制的DNA修复途径,以解决ICLs.
- 证明受损的ICL修复有助于与衰老相关的基因组不稳定性.
- 有证据表明,ICL修复缺陷与某些疾病的发病之间存在联系.
结论:
- 独立于复制的ICL修复途径对于保持基因组完整性至关重要,特别是在非分裂细胞中.
- 功能障碍的ICL修复是细胞衰老和与年龄相关的疾病发病的重要因素.
- 准ICL修复机制可能为癌症和与年龄有关的疾病提供新的治疗策略.
相关概念视频
DNA Damage can Stall the Cell Cycle
9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
Homologous Recombination
50.5K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Fixing Double-strand Breaks
12.6K
The double-stranded structure of DNA has two major advantages. First, it serves as a safe repository of genetic information where one strand serves as the back-up in case the other strand is damaged. Second, the double-helical structure can be wrapped around proteins called histones to form nucleosomes, which can then be tightly wound to form chromosomes. This way, DNA chains up to 2 inches long can be contained within microscopic structures in a cell. A double-stranded break not only damages...
12.6K
Overview of DNA Repair
31.0K
In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
Chemically...
31.0K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


